Immunogenicity and persistence from different 3-dose schedules of live and inactivated polio vaccines in Chinese infants
- PMID: 25681659
- DOI: 10.1016/j.vaccine.2014.08.091
Immunogenicity and persistence from different 3-dose schedules of live and inactivated polio vaccines in Chinese infants
Abstract
Background: OPV is the only poliovirus vaccine used in the China EPI system, although IPV is available in the private market. We compared immunigencity and persistence among different schedules of IPV and OPV.
Methods: 536 Chinese infants were enrolled into 4 groups receiving different schedules administered at 2, 3, and 4 months of age: IPV-OPV-OPV, IPV-IPV-OPV, IPV-IPV-IPV, and OPV-OPV-OPV. The I-I-I group received an 18-month IPV booster dose. Blood samples were collected before the first dose, after the third dose, and at 18 months for all groups, and also after the booster dose for the I-I-I group. Polio neutralizing antibody titers were assessed, and seroprotection rates were calculated after primary immunization and at 18 months of age.
Results: Before the first dose, GMTs of the 4 groups ranged from 2.96 to 6.89, and seroprotection rates ranged from 17.6% to 54.3%. After 3 doses, the GMT of the I-O-O and I-I-O groups ranged from 901.09 to 1,110.12, and the GMT of the I-I-I group range was 212.02 to 537.52, significantly lower than for the 2 sequential schedules (P<0.001). Seroprotection rates were 98.1% to 100%, with no significant differences among groups. At 18 months of age, the GMTs declined to a range of 527.00 to 683.44 in the I-O-O and I-I-O groups, and declined to 150.04 to 239.89 in the I-I-I group, significantly lower than for the other 3 groups (P<0.001).
Conclusions: The sequential schedules achieved high GMTs and seroprotection. The IPV-only schedule achieved high seroprotection but with lower GMTs. Sequential schedules are suitable for China. With the 2 sequential schedules, GMTs remained high at 18 months of age and were not inferior to the OPV-only schedule. Thus, with a sequential schedule, the booster dose could be given at 4 years of age, the same age as the current OPV booster dose.
Keywords: IPV; Immunogencity; OPV; Persistence; Polio vaccine; Sequential schedule.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.J Pediatric Infect Dis Soc. 2016 Sep;5(3):287-96. doi: 10.1093/jpids/piv017. Epub 2015 Apr 16. J Pediatric Infect Dis Soc. 2016. PMID: 26407255
-
[Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jun;46(6):510-3. Zhonghua Yu Fang Yi Xue Za Zhi. 2012. PMID: 22943896 Clinical Trial. Chinese.
-
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318714 Clinical Trial.
-
Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa.Vaccine. 2012 Sep 7;30 Suppl 3:C35-7. doi: 10.1016/j.vaccine.2012.02.056. Vaccine. 2012. PMID: 22939019 Review.
-
Oral and inactivated poliovirus vaccines in the newborn: a review.Vaccine. 2013 May 17;31(21):2517-24. doi: 10.1016/j.vaccine.2012.06.020. Epub 2012 Jun 20. Vaccine. 2013. PMID: 22728224 Free PMC article. Review.
Cited by
-
Immune persistence after different polio sequential immunization schedules in Chinese infants.NPJ Vaccines. 2024 Feb 29;9(1):50. doi: 10.1038/s41541-024-00831-1. NPJ Vaccines. 2024. PMID: 38424078 Free PMC article.
-
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China.Lancet Reg Health West Pac. 2023 Mar 17;34:100725. doi: 10.1016/j.lanwpc.2023.100725. eCollection 2023 May. Lancet Reg Health West Pac. 2023. PMID: 37283972 Free PMC article.
-
Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.Hum Vaccin Immunother. 2021 Jul 3;17(7):2125-2131. doi: 10.1080/21645515.2020.1868269. Epub 2021 Mar 24. Hum Vaccin Immunother. 2021. PMID: 33759702 Free PMC article.
-
Post hoc analysis of two clinical trials to compare the immunogenicity and safety of different polio immunization schedules in Chinese infants.Ann Transl Med. 2021 Feb;9(3):253. doi: 10.21037/atm-20-2537. Ann Transl Med. 2021. PMID: 33708880 Free PMC article.
-
Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.Hum Vaccin Immunother. 2021 Feb 1;17(2):389-396. doi: 10.1080/21645515.2020.1778409. Epub 2020 Jul 23. Hum Vaccin Immunother. 2021. PMID: 32703060 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources